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A recent commentary reignited
discussion within this journal about
the access by clinicians to the updated Australian National Guidelines on
Attention Deficit Hyperactivity Disorder
(ADHD) (The Royal Australian College of Physicians, 2009). We seek to
extend this debate by noting that the
new Diagnostic and Statistical Manual
of Mental Disorders (DSM-5) included
a number of changes to the definition of ADHD. Given the reliance of
these draft national guidelines on the
DSM-IV, it can be expected that the
DSM-5 changes will also have significant impact on the future form of
guidelines, research and clinical practice (Al-Yagon et al., 2013). Further,
the high prevalence of ADHD makes
it important for clinicians to understand these recent changes and their
implications for diagnosis and treatment (Bell, 2011).
There are five major changes in the
new DSM-5. First, a number of examples have been included to elaborate
the types of behavior that people with
ADHD may exhibit across the lifespan.
Second, the age before which symptoms must be manifested has been increased from 7 to 12 years. Third, the
number of symptoms required for
those over 17 years has been reduced
from six to five. Fourth, the previous
exclusion criterion for ADHD and autism has been removed. Finally, greater
emphasis has been placed on the identification of symptoms across several

settings. While the purpose of these
changes is to more accurately incorporate the experience of adults affected by ADHD, possible knock-on
effects to pediatrics have been suggested (Sibley et al., 2013).
Estimated prevalence of ADHD in
Australia is between 5 and 10% (The
Royal Australian College of Physicians, 2009). Historically, changes to
the DSM criteria have resulted in increases in ADHD diagnosis, at times
as much as 15% (Bastra and Frances, 2012). The DSM-5 changes have
the potential for similar increases in
ADHD prevalence and concomitant
psychostimulant treatment (Coghill
and Seth, 2011; Sibley et al., 2013).
However, it is pertinent to examine evidence-based critiques of the
DSM-5 changes and their implications
for clinical practice.
The main critique of the above
changes is that they have not been
fully clinically tested (Coghill and Seth,
2011; Hebebrand and Buitelaar, 2011;
Sibley et al., 2013). Questions have
also been raised about the blurring of
subtypes and the potential for confusion with comorbid conditions (Bastra
and Frances, 2012). For some, this is
a positive move that enables diagnostic practices to cater for individual diversity (Bell, 2011), while for others, it
leaves the potential for greater misdiagnosis (Bastra and Frances, 2012).
The increase of age onset from 7
to 12 years has also been subject to

critique. Although it is acknowledged
that there is no empirical evidence to
support either age (Coghill and Seth,
2011), the lower age has been preferred in the past because it removes
puberty and transition into secondary schooling as confounding variables
that may influence behavior (Bastra
and Frances, 2012). The shift to the
older age is intended to allow more
accurate diagnosis of adolescents and
adults (Bell, 2011). However, lifting the
age of onset, combined with the requirement to show only symptoms
in the past (rather than impairment),
may increase levels of diagnosis (Sibley
et al., 2013).
A less controversial change is the
greater emphasis on identifying difficulties across multiple settings and
the need to rely on reports from
third parties in each of these contexts. Those familiar with the DSMIV might observe that this is little
change from the previous requirements. And while Coghill and Seth
(2011) argue that assessing across
settings is commonplace in the UK,
Epstein and colleagues (2009) have
found that in North America less
than 50% of diagnosticians go beyond
parental reports of a child’s behavior.
There is a lack of empirical evidence
on this trend in Australia.
What the above changes have
in common is the likelihood of increased diagnosis and psychostimulant
treatment (Hebebrand and Buitelaar,
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2011). This would result in a growing demand on clinical services, which
would result in increased health costs
through the MBS and PBS, and possibly in private costs for families. In the
context of existing medical workforce
shortages, already tight time demands
and limited GP training on ADHD,
two outcomes are possible: (i) less
rigorously examined assessments by
GPs, and/or (ii) increased referrals to
psychiatric specialists.
In Australia, only authorized medical practitioners can diagnose ADHD
and prescribe psychostimulants. Best
practice guidelines recommend that
GPs refer to psychiatrists and pediatricians for diagnosis and prescription
(The Royal Australian College of Physicians, 2009). In some states and territories, high levels of demand have
resulted in GPs and psychologists being authorized as delegates to initiate
or continue treatment. In others, the
concentration of ADHD diagnosis in
the hands of a few specialists has also
been noted (Paterson, 2013). Both situations can contribute even further to
a significant difference in prescribing
practices between medical practitioners (Mitchell et al., 2012).
Within the USA, uniformity in diagnostic and prescription practices is
supported by the American Academy
of Child and Adolescent Psychiatry.
In Australia, the Royal Australian and
New Zealand College of Psychiatrists
has produced routine prescribing criteria for ADHD, which some states
(e.g. NSW) use to allow members to
prescribe without seeking individual
approval for each child. However, such
arrangements are not widespread and
the number of child and adolescent
psychiatrists in Australia is in the low
hundreds. This means that many children are treated by private pediatricians, which provides the potential for
idiosyncratic and expensive practice
outside the public system.
Increased referrals will result in
greater demand in relation to number of diagnostic assessments, consultation time and administrative tasks.

With these new referrals will also
come new responsibilities. There will
be more onus on diagnosticians to
test for other disorders prior to assessing for ADHD, and changes to onset age will require greater attention
to the temporal evolution of behaviors (Sibley et al., 2013). Thus, the clinical implications of the new DSM-5
conditions may not only be more presentations, but also more complex
and time-consuming assessment.
The changes in DSM-5 criteria
will also have implications for physicians’ interactions with the education system. An emphasis on including
teacher reports will present a number
of practical difficulties. First, do teachers have the capacity to produce reports that are useful to clinicians? Second, which teachers should report? In
the primary school context (where
a teacher spends hundreds of hours
each year with the same student) this
is less problematic. However, later onset age suggests that there will be increased numbers assessed in the secondary school setting (where any
given teacher may see over 150 students each week for less than one
hour a day). Third, how will clear and
efficient lines of communication be
established?
There are also more general implications. Better communication will be
required between the health professions to facilitate assessment and provide support across multiple settings.
Better understandings of which medical practitioners are assessing who
and where will be needed to target
training on best practice. And, if levels of diagnosis increase, more public
resources will be needed to expand
multi-modal treatment, so that clinicians are not left prescribing medication as the only available support.
Close analysis shows that the
changes in the DSM-5 are more than
just a tweak in terminology. The result is likely to be a growth in levels
of diagnosis and increased demands
on clinical, health and education
professionals.
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